NANOFORM FINLAND OYJ Our impressive achievements have been recognized across the board, with Nanoform shortlisted for four awards across four important events this year!
The exciting potential of Nanoform's biologics technology to enhance drug delivery of biologics and transform patients' care has been recognized by the CPhI Pharma Awards, for which Nanoform has been shortlisted in the Finished Formulation category. These awards celebrate the thinkers and creators driving the industry forward through their innovations, technologies and strategies. The winner will be announced during the award ceremony on November 9th at CPhI Worldwide in Milan.
Meanwhile, our trailblazing progress following our IPO has been recognized by the European Small and Mid-Cap Awards, for which Nanoform has been shortlisted in the Star of Innovation category. This celebrates newly listed mid-caps that place innovation at the centre of their business development strategy. The winner will be announced on November 16th 2021.
In addition, the European Mediscience Awards 2021 showcase achievement and success in the UK and European healthcare, biotech, pharmaceutical and life sciences sectors. Nanoform is a finalist for two European Mediscience Awards - both the Emerging Star and Best Newcomer Award. The winners will be announced on November 16th.
Follow on social media channels for further updates.
Attachments
- Original document
- Permalink
Disclaimer
Nanoform Finland plc published this content on 25 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 October 2021 12:43:04 UTC.
